Prescription drug · NDA
Trulance Immediate release (Plecanatide) NDC 65649-003
Plecanatide 3 mg/1 · Tablet · Oral · Salix Pharmaceuticals Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 65649-003-01 | 6564900030165649000301 | 1 BOTTLE in 1 CARTON (65649-003-01) / 1 TABLET in 1 BOTTLEMarketed from Feb 21, 2017 | |
| 65649-003-03 | 6564900030365649000303 | 1 BOTTLE in 1 CARTON (65649-003-03) / 3 TABLET in 1 BOTTLEMarketed from Feb 21, 2017 | |
| 65649-003-07 | 6564900030765649000307 | 1 BOTTLE in 1 CARTON (65649-003-07) / 7 TABLET in 1 BOTTLEMarketed from Feb 21, 2017 · Sample package | |
| 65649-003-30 | 6564900033065649000330 | 30 TABLET in 1 BOTTLE (65649-003-30)Marketed from Feb 21, 2017 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Trulance Immediate releaseSuffix: Immediate release
- Generic name (nonproprietary)
- plecanatide
- Active ingredients
- Plecanatide — 3 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Salix Pharmaceuticals Inc.NDC labeler code 65649
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 208745
- Marketing start
- Listing expires
- Other FDA classes
- Guanylate Cyclase Activators (Mechanism)
- Identifiers
- Product ID 65649-003_154842e6-a919-ba71-e063-6394a90aebd4SPL ID 154842e6-a919-ba71-e063-6394a90aebd4SPL set ID fe2895bf-71a6-493a-b0ca-e06b2dfefc82RxCUI 1873757, 1873765UNII 7IK8Z952OKUPC 0365649003301
- Pharmacologic class
- Guanylate Cyclase-C Agonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N465649000301followed by a unit qualifier and the quantityPackage 65649-0003-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
TRULANCE is indicated in adults for the treatment of: chronic idiopathic constipation (CIC). irritable bowel syndrome with constipation (IBS-C). TRULANCE is a guanylate cyclase-C agonist indicated in adults for treatment of: chronic idiopathic constipation (CIC). ( 1 ) irritable bowel syndrome with constipation (IBS-C). ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 65649-003
- What is NDC 65649-003?
- 65649-003 is the product NDC for Trulance Immediate release (plecanatide), Plecanatide 3 mg/1 tablet, listed with the FDA by Salix Pharmaceuticals Inc.. It has 4 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Trulance Immediate release (Plecanatide).
- What is the active ingredient?
- Plecanatide.
- Who is the labeler?
- Salix Pharmaceuticals Inc., NDC labeler code 65649. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Trulance Immediate release?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.